RNA分析市場規模、シェア、成長分析：製品別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

RNA分析2023年の市場規模は51億米ドルで、2024年の57億9,000万米ドルから2032年には159億4,000万米ドルに成長し、予測期間中（2025-2032年）のCAGRは13.5%で推移する見通しです。

多くの個人ががん、骨粗しょう症、貧血などの健康問題に直面しているため、慢性的な症状を管理するためにこれらの製品を採用する傾向が高まっていることが、ミネラルサプリメント市場を大きく促進しています。トレント・ファーマシューティカルズ社（Torrent Pharmaceuticals Ltd）の「#BeShelcalStrong」キャンペーンのような大手製薬会社は、カルシウム不足に対する認識を積極的に促進し、より健康的なライフスタイルを奨励しています。座りがちな生活や食生活の乱れが栄養不足に拍車をかけ、疲労や免疫力の低下といった懸念を引き起こしており、特に米国における鉄欠乏症の蔓延が顕著です。この動向に対抗するため、予防的で個別化された健康ソリューションへのシフトが進んでいます。しかし、偽造品やサプライチェーンの混乱といった課題が市場の成長を脅かしています。こうした障害にもかかわらず、革新的な製品開発と植物由来の代替品の増加が有望な機会をもたらしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 顧客と購買基準の分析
• 特許分析
• 技術分析

RNA分析市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 試薬・消耗品
• 機器
• ソフトウェア
• サービス

RNA分析市場規模：技術別& CAGR（2025-2032）

• 市場概要
• ポリメラーゼ連鎖反応
• シーケンシング
• マイクロアレイ
• RNA干渉

RNA分析市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 創薬
• 臨床診断
• 毒性ゲノミクス
• 比較トランスクリプトミクス

RNA分析市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 製薬・バイオテクノロジー企業
• 病院と診断センター
• 学術調査機関
• 契約調査機関

RNA分析市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• AxioMed LLC（U.S.）
• Stryker（U.S.）
• Orthofix（U.S.）
• Globus Medical（U.S.）
• Johnson & Johnson Services, Inc（U.S.）
• B. Braun Melsungen AG（Germany）
• Zimmer Biomet（U.S.）
• Medtronic（Ireland）
• Joimax GmbH（Germany）
• VTI-Vertebral Technologies, Inc（U.S.）
• RTI Surgical（U.S.）
• Synergy Spine Solutions Inc.（Canada）

結論と提言

RNA Analysis Market size was valued at USD 5.1 billion in 2023 and is poised to grow from USD 5.79 billion in 2024 to USD 15.94 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The market for mineral supplements is being significantly propelled by the rising trend in adopting these products for managing chronic conditions, as many individuals face health issues such as cancer, osteoporosis, and anemia. Major pharmaceutical companies, like Torrent Pharmaceuticals Ltd with its #BeShelcalStrong campaign, are actively promoting awareness of calcium deficiency and encouraging healthier lifestyles. Increasing sedentary behavior and poor dietary choices have fueled nutritional deficiencies, leading to concerns like fatigue and weakened immunity, particularly highlighted by the prevalence of iron deficiency in the U.S. To counteract this trend, there is a growing shift towards preventive and personalized health solutions. However, challenges like counterfeit products and supply chain disruptions threaten market growth. Despite these obstacles, innovative product development and a rise in plant-based alternatives present promising opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the RNA Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

RNA Analysis Market Segments Analysis

Global RNA Analysis Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Reagents/Consumables, Instruments, Software and Services. Based on Technology, the market is segmented into Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference. Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Toxicogenomics and Comparative Transcriptomics. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Academic & Research Institutes and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the RNA Analysis Market

The RNA Analysis Market is significantly driven by the growing dependence of the pharmaceutical and biotechnology industries on RNA analysis for the development of targeted therapies, personalized medicine, and groundbreaking drug candidates. As these sectors increasingly seek to enhance therapeutic options and improve patient outcomes, the demand for sophisticated RNA analysis techniques continues to rise. This reliance on RNA analysis not only facilitates the discovery of novel treatments but also plays a crucial role in tailoring medical approaches to individual patients, thereby propelling the overall growth of the market within these dynamic fields.

Restraints in the RNA Analysis Market

The RNA Analysis Market faces a significant restraint due to the complexities involved in interpreting RNA sequencing data, which requires advanced bioinformatics analysis. This process necessitates specialized skills and resources that may not be readily available in all environments, potentially limiting the widespread adoption of RNA sequencing technologies. Organizations lacking the necessary expertise may find it challenging to derive meaningful insights from the data, leading to underutilization of RNA analysis capabilities. As a result, the reliance on specialized personnel and advanced computational infrastructure could pose barriers to growth and innovation within the RNA Analysis Market, impacting its overall development.

Market Trends of the RNA Analysis Market

The RNA Analysis Market is witnessing significant growth driven by advancements in long-read sequencing technologies, which facilitate the comprehensive characterization of full-length RNA molecules. These innovations are crucial for elucidating complex biological processes such as alternative splicing and the identification of diverse isoforms, thereby enhancing our understanding of gene structures. This trend is propelling demand across various sectors, including genomics, biotechnology, and pharmaceuticals, as researchers seek sophisticated methods to unravel intricate genetic mechanisms. As long-read sequencing becomes more accessible and cost-effective, it is poised to transform RNA analysis, leading to breakthroughs in disease research, diagnostics, and therapeutic development.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Patent Analysis
• Technology Analysis

Global RNA Analysis Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents/Consumables
• Instruments
• Software
• Services

Global RNA Analysis Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Polymerase Chain Reaction
• Sequencing
• Microarrays
• RNA Interference

Global RNA Analysis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Clinical Diagnostics
• Toxicogenomics
• Comparative Transcriptomics

Global RNA Analysis Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Academic & Research Institutes
• Contract Research Organizations

Global RNA Analysis Market Size & CAGR (2025-2032)

• North America (Product & Service, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AxioMed LLC (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Joimax GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VTI - Vertebral Technologies, Inc (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Surgical (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synergy Spine Solutions Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations